 |
|
 |
|
|
|
Emergent BioSolutions Inc.
2273 Research Boulevard, Suite 400
Rockville, MD 20850
301-795-1800
Visit Website
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent’s development pipeline includes programs focused on anthrax, botulism, tuberculosis, typhoid, hepatitis B and chlamydia.
Company Management
- Fuad El-Hibri, CEO
- R. Don Elsey, CFO
- R. Don Elsey, Investor Relations Contact
Westwicke Contacts
Request a Meeting
|
|
|
